X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 51 filers reported holding X4 PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,975 | -41.7% | 61,445 | +3.7% | 0.00% | -100.0% |
| Q2 2023 | $114,966 | +41.9% | 59,261 | +532.5% | 0.00% | – |
| Q1 2021 | $81,000 | +35.0% | 9,370 | +0.3% | 0.00% | – |
| Q4 2020 | $60,000 | -7.7% | 9,346 | -2.8% | 0.00% | – |
| Q3 2020 | $65,000 | -29.3% | 9,614 | -2.2% | 0.00% | – |
| Q2 2020 | $92,000 | +1.1% | 9,832 | +7.7% | 0.00% | – |
| Q1 2020 | $91,000 | +13.8% | 9,131 | +22.9% | 0.00% | – |
| Q4 2019 | $80,000 | -15.8% | 7,431 | -0.9% | 0.00% | – |
| Q3 2019 | $95,000 | +41.8% | 7,495 | +68.8% | 0.00% | – |
| Q2 2019 | $67,000 | +570.0% | 4,439 | +705.6% | 0.00% | – |
| Q1 2019 | $10,000 | – | 551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,109,000 | 3.48% |
| SV Health Investors, LLC | 311,490 | $2,109,000 | 1.07% |
| Bain Capital Life Sciences Investors, LLC | 1,648,485 | $11,160,000 | 1.04% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $2,268,000 | 0.91% |
| Ikarian Capital, LLC | 724,680 | $4,907,000 | 0.36% |
| BVF INC/IL | 792,892 | $5,368,000 | 0.29% |
| Opaleye Management Inc. | 75,000 | $508,000 | 0.10% |
| Orbimed Advisors | 1,086,493 | $7,356,000 | 0.09% |
| RA Capital Management | 559,494 | $3,788,000 | 0.07% |
| Bleichroeder LP | 35,730 | $242,000 | 0.04% |